The second RZV dose increased immunity against herpes zoster virus outcomes when administered within an extended window after the first dose.
EMA committee issues positive opinion to support the approval of GSK’s recombinant zoster vaccine, Shingrix in a prefilled syringe: London, UK Wednesday, October 22, 2025, 16:00 ...
Oral and inhaled biologics are gaining R&D investment due to patient acceptance and potential for home administration, with ...
As research becomes ever more sophisticated and regulatory requirements tighten, ProPure ™ is a game-changer for life science ...
The Acute Ischemic Stroke pipeline presents opportunities with 25+ drugs in development across various stages, emphasizing innovative treatments like Prourokinase recombinant, RNS60, and AVLX-144. Key ...
East Idaho News on MSN
What seniors need to know about this fall’s vaccines
Dear Savvy Senior, With a longtime vaccine critic leading the nation’s health departments, can you give me updated ...
Normally, Tau proteins stabilize microtubules and support neuronal function, but in neurodegenerative diseases such as ...
"This is an exhilarating moment for Kraig Labs," said Kim Thompson, Founder and CEO of Kraig Labs. "BAM-1 Alpha represents the next step in the evolution of our spider silk technology. It's the result ...
The drug’s success in a Phase 2 study in alpha-1 antitrypsin deficiency “validates” Sanofi’s 2024 acquisition of Inhibrx, ...
Amicus Therapeutics (FOLD) remains a Buy, driven by strong product momentum and new assets. Read here for more investment ...
Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 studyEfdoralprin alfa ...
Everyday Health on MSN
These Exercises Are Best for Knee Pain, Research Finds
A new scientific analysis determined the best exercises for people with achy, painful knee osteoarthritis. Here’s what it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback